BioSpace News Archive

ATC Alert LLC, a leading Connected Health company, today announced the completion of its acquisition of East Rock Medical Alert’s PERS accounts.

HMS Holdings Corp. (Nasdaq: HMSY) today announced its management team is scheduled to participate in the William Blair 40 th Annual Growth Stock Conference on Tuesday, June 9, 2020, at 9:00 a.m. ET. Management will deliver an HMS overview presentation and participate in a virtual fireside chat session. A webcast and copy of the presentation will be available on the Company’s website at http://investor.hms.com/events-and-presentations .

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has appointed biotech

SurvivorNet, the country’s leading media company for cancer information, today announced it will host its latest virtual conference, “Key Developments in Multiple Myeloma in The Age of COVID-19 and Beyond,” on Thursday, June 4 at 5:30pm ET.

DiscoveryBioMed, Inc . (DBM, www.discoverybiomed.com ) announces a new unit of its contract research organization (CRO) services business called TumorCube that is formed based upon our growing expertise in 3D Biogel-driven bioassays on diseased and normal human cell platform technologies. A trademark application has been filed. “DBM has a growing CRO services business in 3D Biogel-driven bioassays of diseased and

DexCom, Inc. announced that management will present an update on Dexcom at the following upcoming investor conference

Westport, CT, June 04, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that two scientific sessions highlighting PURE EP(tm) System have been accepted into Heart Rhythm Society 2020 Science. The two part set of videos titled ‘Cardiac Signa

June 4, 2020 13:22 UTC Tetraphase terminates merger agreement with AcelRx to enter into merger agreement with Melinta Melinta agreement provides for an aggregate of $39.0 million upfront in cash plus potential contingent value rights cash payments of up to $16.0 million Acquisition Expected to Close in early Q3 2020 WATERTOWN, Mass.--( BUSINESS WIRE )-- Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its

International Process Plants (IPP), a global buyer and seller of pharmaceutical and biopharmaceutical manufacturing facilities and equipment, announced its client AGC Biologics’ successful Q2/20 purchase of a state-of-the-art commercial biopharmaceutical facility in Boulder, Colorado , U.S.A.. The facility, formerly owned by

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with proprietary CBD & CBG infused chewing gums and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that CVS Health Corp. (“CVS”) has approved Tauriga Sciences Inc. to become a Registered Vendor. The Company has activated its CVS Health Vendor Portal account and h